|
|
|
|
|
|
General Information
Shanghai Henghe Pharmaceutical Technology Co., Ltd is a leading process R&D, Intermediates and API manufacturing service provider to the global pharmaceutical industry.
With GMP-Compliance production facilities and Knowledge-based R&D activity, Henghe offers a wide portfolio of high value API and Intermediates to brand companies for the generic Pharmaceutical industry.
Combining cost-effective resources and productivity of China along with unmatched network of high class professionals, Henghe is uniquely positioned to serve global pharmaceutical R&D and manufacturing needs at any level and for any company in this sector.
Please visit our subordinate facility website. |
|
|
| Paclitaxel Intermediates, Etoposide Intermediates, Irinotecan Intermediates, Fludarabine Intermediates, Repaglinide Intermediates, Palonosetron Intermediates, Methotrexate Intermediates, Anastrozole Intermediates, Dolasetron Mesylate Intermediates, Docetaxel Anhydrous , Irinotecan Hydrochloride Trihydrate , Fludarabine Phosphate , Bleomycin Sulfate, Vinorelbine Tartrate , Argatroban , Paclitaxel, Carboplatin Cisplatin Eptaplatin, Oxaliplatin Dolasetron, Gemcitabine HCl, Enocitabine Ifosfamide |
|
|
| Company : |
Shanghai Henghe Pharma-Tech Co., Ltd. |
| Email: |
Contact us |
| URL: |
********
********
|
| Phone: |
*********
|
| Fax : |
*********
|
| Country : |
China |
| Address : |
*********
|
|
|
|
|
|
